Abstract
Stability of an Extemporaneously Formulated Levothyroxine Sodium Syrup Compounded from Commercial Tablets
Author(s): Alexander Kenneth S, Kothapalli Madhu R, Dollimor David
Issue: Jan/Feb 1997 - Hospice Care
Page(s): 60-63
Note: Electronic version includes errata or revisions.
Abstract
The stability of a 40-µg/mL extemporaneously formulated syrup from commercially available levothyroxine sodium tablets, using sorbitol 70% as the diluting vehicle, was studied. The concentration of levothyroxine sodium in the formulation was 40 µg/mL. The protocol included accelerated stability testing at temperatures of 40°, 50°, 60° and 70°C and a high-performance liquid chromatography assay procedure using testosterone propionate as the internal standard. The data were analyzed using an Arrhenius plot to determine the shelf-life of the formulation. The shelf-life was found to be approximately 15 days at 25°C and 47 days at 5°C.
Related Keywords
- Synthroid
Related Categories
- GERIATRICS
- PEDIATRICS
- PEER-REVIEWED
- STABILITIES, COMPATIBILITIES
Related Articles from IJPC
Issue/Page View/Buy |
Title/Author (Click for Abstract / Details / Purchase) |
---|---|
Jan/Feb 1997
Pg. 60-63
|
|
May/Jun 2004
Pg. 181-185
|
Author(s):
Hinkle Amanda R, Newton Gail D
|
Sep/Oct 2000
Pg. 398-399
|
|
Sep/Oct 2015
Pg. 414-419
|
|
Mar/Apr 2018
Pg. 164-171
|
|
Nov/Dec 2000
Pg. 482-483
|
Author(s):
Gupta Vishnu D
|
May/Jun 2004
Pg. 206-209
|
Author(s):
Allen Loyd V Jr
|
Jan/Feb 2020
Pg. 77-82
|
|
Jul/Aug 2012
Pg. 342-346
|
|
Jul/Aug 2018
Pg. 326-328
|
|
Nov/Dec 2013
Pg. 505
|
Author(s):
Allen Loyd V Jr
|
May/Jun 2007
Pg. 247
|
Author(s):
Allen Loyd V Jr
|
Jul/Aug 2004
Pg. 269-274
|
Author(s):
Helmke Christopher D
|
Sep/Oct 2015
Pg. 428-431
|
Author(s):
Nahata Milap C
|
Jan/Feb 2021
Pg. 82-87
|
|
Sep/Oct 2021
Pg. 431-439
|
|
May/Jun 2022
Pg. 255-263
|
|
May/Jun 2002
Pg. 226-229
|
Author(s):
Zhang Yanping, Trissel Lawrence A
|
Mar/Apr 2020
Pg. 148-155
|
|
May/Jun 2003
Pg. 233-239
|